3 completed, 3 terminated, 2 active not recruiting, 1 withdrawn. 9 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 9 | Completed 3, Terminated 3, Active not recruiting 2, Withdrawn 1 |
| Phase 1 | 1 | Withdrawn 1 |
| Phase 3 | 1 | Completed 1 |
Follow Methylphenidate Hydrochloride: new trials by email Literature Review of Methylphenidate Hydrochloride trials Research Report on Methylphenidate Hydrochloride
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Methylphenidate in Childhood Apraxia of Speech Methylphenidate Hydrochloride, Placebo - Childhood Apraxia of Speech | Phase 2 | Completed | Murdoch Childrens Research Institute | 18 | 2022-03-14 | 2026-10-13 |
| Investigating the Impact of Methylphenidate on Neural Response in Disruptive Behavioral Disorder Methylphenidate Hydrochloride - Conduct Disorder, Attention Defict Hyperactivity Disorder | Phase 1 / Phase 2 | Withdrawn | National Institute of Mental Health (NIMH) | 2014-09-04 | 2019-12-03 | |
| Cognitive Behavioral Therapy and Multimodal Therapy in Treating Sleep Disturbance in Patients With Cancer Counseling, Methylphenidate Hydrochloride, Phototherapy - Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm | Phase 2 | Active not recruiting | M.D. Anderson Cancer Center | 68 | 2014-01-15 | 2026-05-22 |
| The Effect Methylphenidate Hydrochloride on Pain and Auditory Sensitivity in Healthy Subjects methylphenidate hydrochloride, Sugar pill (placebo) - Pharmacological Action (PA) | Phase 2 | Completed | Rambam Health Care Campus | 41 | 2013-07-01 | 2017-09-12 |
| Multimodal Therapy for the Treatment of Fatigue in Patients With Prostate Cancer Receiving Radiotherapy With Androgen Deprivation Therapy Placebo, Methylphenidate, Counseling Sessions - Prostate Cancer | Phase 2 | Active not recruiting | M.D. Anderson Cancer Center | 175 | 2012-02-08 | 2026-09-03 |
| Methylphenidate HCl or Modafinil in Treating Young Patients With Excessive Daytime Sleepiness After Cancer Therapy methylphenidate hydrochloride, modafinil, placebo - Central Nervous System Tumor, Pediatric, Fatigue | Phase 2 | Terminated | University of South Florida | 1 | 2010-07-01 | 2014-02-21 |
| Efficacy Study of Methylphenidate Hydrochloride to Reduce Fatigue in Prostate Cancer Patients Receiving Hormone Therapy Methylphenidate Hydrochloride, Matched Placebo - Prostatic Neoplasms, Fatigue | Phase 2 | Terminated | University Health Network, Toronto | 33 | 2008-01-01 | 2014-06-04 |
| Methylphenidate Treatment of Cancer-Related Fatigue Methylphenidate hydrochloride, Placebo - Cancer-related Fatigue | Phase 2 / Phase 3 | Completed | Medice Arzneimittel Pütter GmbH & Co KG | 66 | 2006-08-01 | 2010-01-13 |
| Adderall XR Compared With Concerta in Treating Young Cancer Patients With Memory, Attention, and Depression Adderall-XR®, Concerta® - Depression, Neurotoxicity | Phase 2 | Terminated | University of South Florida | 12 | 2003-08-01 | 2014-02-03 |
Fatigue (4) · Prostatic Neoplasms (2) · Sleep Wake Disorders (2) · Apraxias (1) · Attention Deficit Disorder with Hyperactivity (1) · Attention Deficit and Disruptive Behavior Disorders (1) · Central Nervous System Neoplasms (1) · Conduct Disorder (1) · Depression (1) · Hematologic Neoplasms (1) · Neoplasms (1) · Neurotoxicity Syndromes (1) · Speech Intelligibility (1)
M.D. Anderson Cancer Center (2) · University of South Florida (2) · Medice Arzneimittel Pütter GmbH & Co KG (1) · Murdoch Childrens Research Institute (1) · National Institute of Mental Health (NIMH) (1) · Rambam Health Care Campus (1) · University Health Network, Toronto (1)
United States (3) · Australia (1) · Canada (1) · Germany (1) · Israel (1)
Angela Morgan, PhD (1) · Elon Eisenberg, MD (1) · Gerald Rosen, MD (1) · James J Blair, Ph.D. (1) · Manfred Heim, Prof. (1) · Margaret Booth-Jones, PhD (1) · Neil E Fleshner, MD (1) · Shabbir MH Alibhai, MD (1) · Sriram Yennu (1) · Sriram Yennurajalingam, MD (1) · Tom Geller, MD (1)
U10CA081920 (2)